Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
22.6M
-
Shares change
-
+2.69M
-
Total reported value, excl. options
-
$22.2M
-
Value change
-
+$2.03M
-
Put/Call ratio
-
1.09
-
Number of buys
-
19
-
Number of sells
-
-33
-
Price
-
$0.99
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q2 2017
63 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q2 2017.
REGULUS THERAPEUTICS INC - COM (RGLS) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.6M shares
.
Largest 10 shareholders include FMR LLC (7.98M shares), EcoR1 Capital, LLC (3.71M shares), BVF INC/IL (3.28M shares), VANGUARD GROUP INC (1.47M shares), South Dakota Investment Council (1.33M shares), WELLS FARGO & COMPANY/MN (698K shares), RHENMAN & PARTNERS ASSET MANAGEMENT AB (594K shares), BlackRock Inc. (530K shares), MILLENNIUM MANAGEMENT LLC (470K shares), and GOLDMAN SACHS GROUP INC (368K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.